The global atherectomy devices market size accounted for USD 1.12 billion in 2025 and is forecasted to hit around USD 2.27 billion by 2034, representing a CAGR of 8.12% from 2025 to 2034. The North America market size was estimated at USD 440 million in 2024 and is expanding at a CAGR of 8.11% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Atherectomy Devices Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Atherectomy Devices Market Revenue and Volume, by Devices Type
8.1.1 Atherectomy Devices
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Angioplasty Balloon Catheters
8.1.2.1. Market Revenue and Volume Forecast
8.1.3. Stents (Bare-Metal, Drug-Eluting, Bioresorbable)
8.1.3.1. Market Revenue and Volume Forecast
8.1.4. Intravascular Ultrasound (IVUS) Catheters
8.1.4.1. Market Revenue and Volume Forecast
8.1.5. Optical Coherence Tomography (OCT) Catheters
8.1.5.1. Market Revenue and Volume Forecast
8.1.6. Drug-Coated Balloons
8.1.6.1. Market Revenue and Volume Forecast
8.1.7. Embolic Protection Devices
8.1.7.1. Market Revenue and Volume Forecast
8.1.8. Thrombectomy Devices
8.1.8.1. Market Revenue and Volume Forecast
8.1.9. Aortic Stent Grafts
8.1.9.1. Market Revenue and Volume Forecast
8.1.10. Endovascular Grafts
8.1.10.1. Market Revenue and Volume Forecast
8.1.11. Laser Atherectomy Devices
8.1.11.1. Market Revenue and Volume Forecast
8.1.12. Orbital Atherectomy Systems
8.1.12.1. Market Revenue and Volume Forecast
8.1.13. Rotational Atherectomy Devices
8.1.13.1. Market Revenue and Volume Forecast
8.1.14. Directional Atherectomy Devices
8.1.14.1. Market Revenue and Volume Forecast
8.1.15. Chronic Total Occlusion (CTO) Devices
8.1.15.1. Market Revenue and Volume Forecast
9.1. Atherectomy Devices Market Revenue and Volume, by Application
9.1.1. Peripheral Artery Disease (PAD) Treatment Devices
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Coronary Artery Disease (CAD) Intervention Devices
9.1.2.1. Market Revenue and Volume Forecast
9.1.3. Carotid Artery Disease Intervention Devices
9.1.3.1. Market Revenue and Volume Forecast
9.1.4. Renal Artery Disease Intervention Devices
9.1.4.1. Market Revenue and Volume Forecast
9.1.5. Aortic Atherosclerosis Intervention Devices
9.1.5.1. Market Revenue and Volume Forecast
10.1. Atherectomy Devices Market Revenue and Volume, by End-user
10.1.1. Cardiac Catheterization Labs
10.1.1.1. Market Revenue and Volume Forecast
10.1.2. Interventional Radiology Departments
10.1.2.1. Market Revenue and Volume Forecast
10.1.3. Vascular Surgery Centers
10.1.3.1. Market Revenue and Volume Forecast
10.1.4. Cardiology Clinics
10.1.4.1. Market Revenue and Volume Forecast
10.1.5. Academic Research Institutions
10.1.5.1. Market Revenue and Volume Forecast
11.1. North America
11.1.1. Market Revenue and Volume Forecast, by Devices Type
11.1.2. Market Revenue and Volume Forecast, by Application
11.1.3. Market Revenue and Volume Forecast, by End-user
11.1.4. U.S.
11.1.4.1. Market Revenue and Volume Forecast, by Devices Type
11.1.4.2. Market Revenue and Volume Forecast, by Application
11.1.4.3. Market Revenue and Volume Forecast, by End-user
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Volume Forecast, by Devices Type
11.1.5.2. Market Revenue and Volume Forecast, by Application
11.1.5.3. Market Revenue and Volume Forecast, by End-user
11.2. Europe
11.2.1. Market Revenue and Volume Forecast, by Devices Type
11.2.2. Market Revenue and Volume Forecast, by Application
11.2.3. Market Revenue and Volume Forecast, by End-user
11.2.4. UK
11.2.4.1. Market Revenue and Volume Forecast, by Devices Type
11.2.4.2. Market Revenue and Volume Forecast, by Application
11.2.4.3. Market Revenue and Volume Forecast, by End-user
11.2.5. Germany
11.2.5.1. Market Revenue and Volume Forecast, by Devices Type
11.2.5.2. Market Revenue and Volume Forecast, by Application
11.2.5.3. Market Revenue and Volume Forecast, by End-user
11.2.6. France
11.2.6.1. Market Revenue and Volume Forecast, by Devices Type
11.2.6.2. Market Revenue and Volume Forecast, by Application
11.2.6.3. Market Revenue and Volume Forecast, by End-user
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Volume Forecast, by Devices Type
11.2.7.2. Market Revenue and Volume Forecast, by Application
11.2.7.3. Market Revenue and Volume Forecast, by End-user
11.3. APAC
11.3.1. Market Revenue and Volume Forecast, by Devices Type
11.3.2. Market Revenue and Volume Forecast, by Application
11.3.3. Market Revenue and Volume Forecast, by End-user
11.3.4. India
11.3.4.1. Market Revenue and Volume Forecast, by Devices Type
11.3.4.2. Market Revenue and Volume Forecast, by Application
11.3.4.3. Market Revenue and Volume Forecast, by End-user
11.3.5. China
11.3.5.1. Market Revenue and Volume Forecast, by Devices Type
11.3.5.2. Market Revenue and Volume Forecast, by Application
11.3.5.3. Market Revenue and Volume Forecast, by End-user
11.3.6. Japan
11.3.6.1. Market Revenue and Volume Forecast, by Devices Type
11.3.6.2. Market Revenue and Volume Forecast, by Application
11.3.6.3. Market Revenue and Volume Forecast, by End-user
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Volume Forecast, by Devices Type
11.3.7.2. Market Revenue and Volume Forecast, by Application
11.3.7.3. Market Revenue and Volume Forecast, by End-user
11.4. MEA
11.4.1. Market Revenue and Volume Forecast, by Devices Type
11.4.2. Market Revenue and Volume Forecast, by Application
11.4.3. Market Revenue and Volume Forecast, by End-user
11.4.4. GCC
11.4.4.1. Market Revenue and Volume Forecast, by Devices Type
11.4.4.2. Market Revenue and Volume Forecast, by Application
11.4.4.3. Market Revenue and Volume Forecast, by End-user
11.4.5. North Africa
11.4.5.1. Market Revenue and Volume Forecast, by Devices Type
11.4.5.2. Market Revenue and Volume Forecast, by Application
11.4.5.3. Market Revenue and Volume Forecast, by End-user
11.4.6. South Africa
11.4.6.1. Market Revenue and Volume Forecast, by Devices Type
11.4.6.2. Market Revenue and Volume Forecast, by Application
11.4.6.3. Market Revenue and Volume Forecast, by End-user
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Volume Forecast, by Devices Type
11.4.7.2. Market Revenue and Volume Forecast, by Application
11.4.7.3. Market Revenue and Volume Forecast, by End-user
11.5. Latin America
11.5.1. Market Revenue and Volume Forecast, by Devices Type
11.5.2. Market Revenue and Volume Forecast, by Application
11.5.3. Market Revenue and Volume Forecast, by End-user
11.5.4. Brazil
11.5.4.1. Market Revenue and Volume Forecast, by Devices Type
11.5.4.2. Market Revenue and Volume Forecast, by Application
11.5.4.3. Market Revenue and Volume Forecast, by End-user
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Volume Forecast, by Devices Type
11.5.5.2. Market Revenue and Volume Forecast, by Application
11.5.5.3. Market Revenue and Volume Forecast, by End-user
12.1. Abbott Laboratories
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Boston Scientific Corporation
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. BD
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Cardinal Health Inc.
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Koninklijke Philips NV
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Medtronic Plc
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Terumo Corporation
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Avinger
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Cardiovascular Systems
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Ra Medical Systems
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample